CAPTRUST Financial Advisors
ACUR

CAPTRUST Financial Advisors’s Acura Pharmaceuticals ACUR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-245
Closed – – 5354
2022
Q1 		$0 Hold
245
– – ﹤0.01% 5346
2021
Q4 		$0 Hold
245
– – ﹤0.01% 5115
2021
Q3 		$0 Hold
245
– – ﹤0.01% 4947
2021
Q2 		$0 Hold
245
– – ﹤0.01% 4851
2021
Q1 		$0 Hold
245
– – ﹤0.01% 4639
2020
Q4 		$0 Hold
245
– – ﹤0.01% 3651
2020
Q3 		$0 Hold
245
– – ﹤0.01% 3395
2020
Q2 		$0 Buy
+245
New – ﹤0.01% 2962

CAPTRUST Financial Advisors's ACUR Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of Acura Pharmaceuticals (ACUR) in Q2 2022, closing a stake of 245 shares.

CAPTRUST Financial Advisors first reported a position in ACUR in Q2 2020 and held it in 8 quarters. The position peaked at $0 in Q1 2022. 0 funds tracked by Wall St. Rank hold ACUR as of Q2 2022.

  • CAPTRUST Financial Advisors reported no remaining Acura Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 245 Acura Pharmaceuticals shares in Q2 2022.
  • CAPTRUST Financial Advisors first reported a position in Acura Pharmaceuticals in Q2 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Acura Pharmaceuticals position peaked at $0 in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.